{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:58:08Z","timestamp":1793217488897,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Microbiol Immunol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00430-016-0451-4","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T04:24:42Z","timestamp":1456892682000},"page":"201-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Eradication of measles: remaining challenges"],"prefix":"10.1007","volume":"205","author":[{"given":"Heidemarie","family":"Holzmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Hengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Tenbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. W.","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"issue":"2","key":"451_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.4457","volume":"235","author":"M Ludlow","year":"2015","unstructured":"Ludlow M et al (2015) Pathological consequences of systemic measles virus infection. J Pathol 235(2):253\u2013265","journal-title":"J Pathol"},{"key":"451_CR2","first-page":"1042","volume-title":"Measles, in Fields Virology","author":"DE Griffin","year":"2013","unstructured":"Griffin DE (2013) Measles, in Fields Virology. Wolters Kluwer\/Lippincott, Williams & Wilkins, Philadelphia, pp 1042\u20131069"},{"issue":"6235","key":"451_CR3","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1126\/science.aaa3662","volume":"348","author":"MJ Mina","year":"2015","unstructured":"Mina MJ et al (2015) Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science 348(6235):694\u2013699","journal-title":"Science"},{"issue":"8","key":"451_CR4","doi-asserted-by":"crossref","first-page":"e1002885","DOI":"10.1371\/journal.ppat.1002885","volume":"8","author":"RD Vries de","year":"2012","unstructured":"de Vries RD et al (2012) Measles immune suppression: lessons from the macaque model. PLoS Pathog 8(8):e1002885","journal-title":"PLoS Pathog"},{"key":"451_CR5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/B978-1-4557-0090-5.00028-8","volume-title":"Vaccines","author":"P Strebel","year":"2013","unstructured":"Strebel P et al (2013) Measles vaccine. In: Plotkin S, Orenstein WA, Offit P (eds) Vaccines, 6th edn. Elsevier, Amsterdam, pp 352\u2013387","edition":"6"},{"issue":"9","key":"451_CR6","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/jmv.22152","volume":"83","author":"E Moulin","year":"2011","unstructured":"Moulin E et al (2011) Molecular characterization of measles virus strains causing subacute sclerosing panencephalitis in France in 1977 and 2007. J Med Virol 83(9):1614\u20131623","journal-title":"J Med Virol"},{"issue":"3","key":"451_CR7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00430-010-0153-2","volume":"199","author":"D Reuter","year":"2010","unstructured":"Reuter D, Schneider-Schaulies J (2010) Measles virus infection of the CNS: human disease, animal models, and approaches to therapy. Med Microbiol Immunol 199(3):261\u2013271","journal-title":"Med Microbiol Immunol"},{"issue":"7","key":"451_CR8","doi-asserted-by":"crossref","first-page":"e68909","DOI":"10.1371\/journal.pone.0068909","volume":"8","author":"K Schonberger","year":"2013","unstructured":"Schonberger K et al (2013) Epidemiology of subacute sclerosing panencephalitis (SSPE) in Germany from 2003 to 2009: a risk estimation. PLoS ONE 8(7):e68909","journal-title":"PLoS ONE"},{"key":"451_CR9","doi-asserted-by":"crossref","unstructured":"Roberts L (2015) Is measles next? Science 348(6238):958\u2013961, 963","DOI":"10.1126\/science.348.6238.958"},{"key":"451_CR10","unstructured":"European Centre for Disease Prevention and Control, Betsch C (2014) Measles and rubella elimination: communicating the importance of vaccination. Stockholm"},{"key":"451_CR11","first-page":"349","volume":"84","author":"WHO","year":"2015","unstructured":"WHO (2015) Measles vaccines: WHO position paper. WHO Wkly Epidemiol Rec 84:349\u2013360","journal-title":"WHO Wkly Epidemiol Rec"},{"key":"451_CR12","first-page":"681","volume":"90","author":"WHO","year":"2015","unstructured":"WHO (2015) Meeting of the Strategic Advisory Group of Experts on immunization, October 2015\u2014conclusions and recommendations. WHO Wkly Epidemiol Rec 90:681\u2013700","journal-title":"WHO Wkly Epidemiol Rec"},{"issue":"4","key":"451_CR13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/adc.2006.113076","volume":"93","author":"T Egami","year":"2008","unstructured":"Egami T, Egami K, Tanoue A (2008) Study of antibody titres after measles vaccination: fever within 7\u00a0days of vaccination and efficacy of booster doses. Arch Dis Child 93(4):319\u2013320","journal-title":"Arch Dis Child"},{"issue":"48","key":"451_CR14","doi-asserted-by":"crossref","first-page":"5766","DOI":"10.1016\/j.vaccine.2013.08.044","volume":"31","author":"C Martins","year":"2013","unstructured":"Martins C et al (2013) Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9\u00a0months or at 9 and 18\u00a0months of age: a serological study within a randomised trial of different measles vaccines. Vaccine 31(48):5766\u20135771","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"451_CR15","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/infdis\/jir102","volume":"204","author":"A Uzicanin","year":"2011","unstructured":"Uzicanin A, Zimmerman L (2011) Field effectiveness of live attenuated measles-containing vaccines: a review of published literature. J Infect Dis 204(Suppl 1):S133\u2013S148","journal-title":"J Infect Dis"},{"issue":"3","key":"451_CR16","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/cid\/cis439","volume":"55","author":"G Serres De","year":"2012","unstructured":"De Serres G et al (2012) Higher risk of measles when the first dose of a 2-dose schedule of measles vaccine is given at 12\u201314\u00a0months versus 15\u00a0months of age. Clin Infect Dis 55(3):394\u2013402","journal-title":"Clin Infect Dis"},{"issue":"6","key":"451_CR17","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2004-2718","volume":"116","author":"LF Yeung","year":"2005","unstructured":"Yeung LF et al (2005) A limited measles outbreak in a highly vaccinated US boarding school. Pediatrics 116(6):1287\u20131291","journal-title":"Pediatrics"},{"issue":"Suppl 1","key":"451_CR18","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1086\/377699","volume":"189","author":"TV Lynn","year":"2004","unstructured":"Lynn TV et al (2004) Incremental effectiveness of 2 doses of measles-containing vaccine compared with 1 dose among high school students during an outbreak. J Infect Dis 189(Suppl 1):S86\u2013S90","journal-title":"J Infect Dis"},{"issue":"22","key":"451_CR19","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMms1215400","volume":"369","author":"WG Panhuis van","year":"2013","unstructured":"van Panhuis WG et al (2013) Contagious diseases in the United States from 1888 to the present. N Engl J Med 369(22):2152\u20132158","journal-title":"N Engl J Med"},{"issue":"7","key":"451_CR20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1086\/528993","volume":"197","author":"I Davidkin","year":"2008","unstructured":"Davidkin I et al (2008) Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis 197(7):950\u2013956","journal-title":"J Infect Dis"},{"key":"451_CR21","unstructured":"WHO (2015) GIVS: Global immunization vision and strategy 2006\u20132015. World Health Organization and UNICEF"},{"key":"451_CR22","unstructured":"WHO (2010) Global eradication of measles. Sixty-Third World Health Assembly"},{"issue":"1","key":"451_CR23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11262-015-1173-1","volume":"50","author":"S Santibanez","year":"2015","unstructured":"Santibanez S et al (2015) Long-term transmission of measles virus in Central and continental Western Europe. Virus Genes 50(1):2\u201311","journal-title":"Virus Genes"},{"key":"451_CR24","unstructured":"WHO (2012) Global measles and rubella strategie plan: 2012\u20132020. World Health Organization, Geneva, pp 1\u201343"},{"key":"451_CR25","first-page":"617","volume":"46","author":"WHO","year":"2015","unstructured":"WHO (2015) Global routine vaccination coverage, 2014. WHO Wkly Epidemiol Rec 46:617\u2013632","journal-title":"WHO Wkly Epidemiol Rec"},{"issue":"6","key":"451_CR26","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00430-014-0346-1","volume":"203","author":"HW Doerr","year":"2014","unstructured":"Doerr HW, Berger A (2014) Vaccination against infectious diseases: what is promising? Med Microbiol Immunol 203(6):365\u2013371","journal-title":"Med Microbiol Immunol"},{"issue":"Suppl 1","key":"451_CR27","doi-asserted-by":"crossref","first-page":"S533","DOI":"10.1093\/infdis\/jir097","volume":"204","author":"B Bankamp","year":"2011","unstructured":"Bankamp B et al (2011) Genetic characterization of measles vaccine strains. J Infect Dis 204(Suppl 1):S533\u2013S548","journal-title":"J Infect Dis"},{"issue":"9","key":"451_CR28","doi-asserted-by":"crossref","first-page":"6123","DOI":"10.4049\/jimmunol.179.9.6123","volume":"179","author":"M Shingai","year":"2007","unstructured":"Shingai M et al (2007) Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 179(9):6123\u20136133","journal-title":"J Immunol"},{"issue":"Pt 11","key":"451_CR29","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1099\/0022-1317-83-11-2699","volume":"83","author":"S Santibanez","year":"2002","unstructured":"Santibanez S et al (2002) Rapid replacement of endemic measles virus genotypes. J Gen Virol 83(Pt 11):2699\u20132708","journal-title":"J Gen Virol"},{"issue":"6","key":"451_CR30","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1128\/JVI.03029-12","volume":"87","author":"M Tahara","year":"2013","unstructured":"Tahara M et al (2013) The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope. J Virol 87(6):3583\u20133586","journal-title":"J Virol"},{"issue":"1","key":"451_CR31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1128\/JVI.02033-12","volume":"87","author":"M Tahara","year":"2013","unstructured":"Tahara M et al (2013) Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein. J Virol 87(1):666\u2013675","journal-title":"J Virol"},{"issue":"Pt 2","key":"451_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1099\/vir.0.80467-0","volume":"86","author":"S Santibanez","year":"2005","unstructured":"Santibanez S et al (2005) Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies? J Gen Virol 86(Pt 2):365\u2013374","journal-title":"J Gen Virol"},{"key":"451_CR33","first-page":"129","volume":"330","author":"PA Rota","year":"2009","unstructured":"Rota PA, Featherstone DA, Bellini WJ (2009) Molecular epidemiology of measles virus. Curr Top Microbiol Immunol 330:129\u2013150","journal-title":"Curr Top Microbiol Immunol"},{"issue":"4","key":"451_CR34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/aje\/kwt282","volume":"179","author":"GD Shanks","year":"2014","unstructured":"Shanks GD et al (2014) Measles epidemics of variable lethality in the early 20th century. Am J Epidemiol 179(4):413\u2013422","journal-title":"Am J Epidemiol"},{"issue":"8","key":"451_CR35","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3201\/eid1708.101994","volume":"17","author":"A Mankertz","year":"2011","unstructured":"Mankertz A et al (2011) Spread of measles virus D4-Hamburg, Europe, 2008\u20132011. Emerg Infect Dis 17(8):1396\u20131401","journal-title":"Emerg Infect Dis"},{"key":"451_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2015.03.012","volume":"67","author":"C Moore","year":"2015","unstructured":"Moore C et al (2015) Self-collected buccal swabs and rapid, real-time PCR during a large measles outbreak in Wales: evidence for the protective effect of prior MMR immunisation. J Clin Virol 67:1\u20137","journal-title":"J Clin Virol"},{"issue":"1","key":"451_CR37","first-page":"33","volume":"55","author":"MF Allam","year":"2014","unstructured":"Allam MF (2014) New measles vaccination schedules in the European countries? J Prev Med Hyg 55(1):33\u201334","journal-title":"J Prev Med Hyg"},{"issue":"1","key":"451_CR38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/AOG.0000000000000903","volume":"126","author":"SA Rasmussen","year":"2015","unstructured":"Rasmussen SA, Jamieson DJ (2015) What obstetric health care providers need to know about measles and pregnancy. Obstet Gynecol 126(1):163\u2013170","journal-title":"Obstet Gynecol"},{"issue":"11","key":"451_CR39","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00103-007-0195-9","volume":"50","author":"M Enders","year":"2007","unstructured":"Enders M, Biber M, Exler S (2007) Measles, mumps and rubella virus infection in pregnancy. Possible adverse effects on pregnant women, pregnancy outcome and the fetus. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 50(11):1393\u20131398","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"8","key":"451_CR40","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/cid\/ciu037","volume":"58","author":"IU Ogbuanu","year":"2014","unstructured":"Ogbuanu IU et al (2014) Maternal, fetal, and neonatal outcomes associated with measles during pregnancy: Namibia, 2009\u20132010. Clin Infect Dis 58(8):1086\u20131092","journal-title":"Clin Infect Dis"},{"issue":"8957","key":"451_CR41","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0140-6736(95)90858-7","volume":"345","author":"K Zwiauer","year":"1995","unstructured":"Zwiauer K et al (1995) Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles virus infection. Lancet 345(8957):1124","journal-title":"Lancet"},{"issue":"9","key":"451_CR42","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1651-2227.2004.tb02758.x","volume":"93","author":"M Dasopoulou","year":"2004","unstructured":"Dasopoulou M, Covanis A (2004) Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatr 93(9):1251\u20131253","journal-title":"Acta Paediatr"},{"issue":"1","key":"451_CR43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1403494815610182","volume":"44","author":"GA Williams","year":"2016","unstructured":"Williams GA et al (2016) Measles among migrants in the European Union and the European Economic Area. Scand J Public Health\u00a044(1):6\u201313","journal-title":"Scand J Public Health"},{"issue":"45","key":"451_CR44","first-page":"1031","volume":"63","author":"OM Kew","year":"2014","unstructured":"Kew OM et al (2014) Possible eradication of wild poliovirus type 3\u2013worldwide, 2012. Morb Mortal Wkly Rep 63(45):1031\u20131033","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"451_CR45","doi-asserted-by":"crossref","first-page":"e88442","DOI":"10.1371\/journal.pone.0088442","volume":"9","author":"S Sharif","year":"2014","unstructured":"Sharif S et al (2014) Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009\u2013February 2011. PLoS ONE 9(2):e88442","journal-title":"PLoS ONE"},{"issue":"7","key":"451_CR46","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/cid\/ciu1136","volume":"60","author":"LM Shulman","year":"2015","unstructured":"Shulman LM et al (2015) Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with\u00a0>95% vaccine coverage, Israel 2013. Clin Infect Dis 60(7):1057\u20131064","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"451_CR47","doi-asserted-by":"crossref","first-page":"S324","DOI":"10.1093\/infdis\/jiu160","volume":"210","author":"MM Alam","year":"2014","unstructured":"Alam MM et al (2014) Detection of multiple cocirculating wild poliovirus type 1 lineages through environmental surveillance: impact and progress during 2011-2013 in Pakistan. J Infect Dis 210(Suppl 1):S324\u2013S332","journal-title":"J Infect Dis"},{"key":"451_CR48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2334-12-24","volume":"12","author":"C Reinheimer","year":"2012","unstructured":"Reinheimer C et al (2012) Deficiency of immunity to poliovirus type 3: a lurking danger? BMC Infect Dis 12:24","journal-title":"BMC Infect Dis"},{"issue":"6","key":"451_CR49","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/infdis\/jis923","volume":"207","author":"G Serres De","year":"2013","unstructured":"De Serres G et al (2013) Largest Measles Epidemic in North America in a Decade-Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis 207(6):990\u2013998","journal-title":"J Infect Dis"},{"issue":"5","key":"451_CR50","doi-asserted-by":"crossref","first-page":"e1126","DOI":"10.1542\/peds.2012-3975","volume":"132","author":"F Defay","year":"2013","unstructured":"Defay F et al (2013) Measles in children vaccinated with 2 doses of MMR. Pediatrics 132(5):e1126\u2013e1133","journal-title":"Pediatrics"},{"key":"451_CR51","doi-asserted-by":"crossref","unstructured":"Santibanez S et al (2014) Measles virus spread initiated at international mass gatherings in Europe, 2011. Euro Surveill 19(35). doi: 10.2807\/1560-7917.es2014.19.35.20891","DOI":"10.2807\/1560-7917.ES2014.19.35.20891"},{"issue":"6","key":"451_CR52","first-page":"153","volume":"64","author":"J Zipprich","year":"2015","unstructured":"Zipprich J et al (2015) Measles outbreak\u2013California, December 2014-February 2015. Morb Mortal Wkly Rep 64(6):153\u2013154","journal-title":"Morb Mortal Wkly Rep"},{"issue":"10","key":"451_CR53","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/infdis\/jis568","volume":"206","author":"M Kontio","year":"2012","unstructured":"Kontio M et al (2012) Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 206(10):1542\u20131548","journal-title":"J Infect Dis"},{"issue":"39","key":"451_CR54","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1016\/j.vaccine.2015.08.057","volume":"33","author":"G Goncalves","year":"2015","unstructured":"Goncalves G et al (2015) Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal. Vaccine 33(39):5057\u20135063","journal-title":"Vaccine"},{"key":"451_CR55","doi-asserted-by":"crossref","first-page":"c7452","DOI":"10.1136\/bmj.c7452","volume":"342","author":"F Godlee","year":"2011","unstructured":"Godlee F, Smith J, Marcovitch H (2011) Wakefield\u2019s article linking MMR vaccine and autism was fraudulent. BMJ 342:c7452","journal-title":"BMJ"},{"key":"451_CR56","unstructured":"WHO (2015) SAGE, vaccine hesitancy. Vaccine 33"},{"key":"451_CR57","unstructured":"Aufkl\u00e4rung BFG (2011) Elternbefragung zum Thema \u201cImpfen im Kindesalter\u201d. forsa-Gesellschaft f\u00fcr Sozialforschung und Statistische Analysen"},{"issue":"32","key":"451_CR58","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1016\/j.vaccine.2011.05.046","volume":"29","author":"M Paulke-Korinek","year":"2011","unstructured":"Paulke-Korinek M et al (2011) Persistence of antibodies in 4\u20138\u00a0year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV\/Hib and MMR vaccines. Vaccine 29(32):5130\u20135136","journal-title":"Vaccine"},{"issue":"3","key":"451_CR59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00430-007-0036-3","volume":"196","author":"S Wicker","year":"2007","unstructured":"Wicker S et al (2007) Seroprevalence of vaccine preventable and blood transmissible viral infections (measles, mumps, rubella, polio, HBV, HCV and HIV) in medical students. Med Microbiol Immunol 196(3):145\u2013150","journal-title":"Med Microbiol Immunol"},{"key":"451_CR60","first-page":"89","volume":"88","author":"WHO","year":"2013","unstructured":"WHO (2013) WHO framework for verifying elimination of measles and rubella. WHO Wkly Epidemiol Record 88:89\u2013100","journal-title":"WHO Wkly Epidemiol Record"},{"issue":"3","key":"451_CR61","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jcv.2004.05.007","volume":"31","author":"A Tischer","year":"2004","unstructured":"Tischer A et al (2004) Laboratory investigations are indispensable to monitor the progress of measles elimination\u2013results of the German Measles Sentinel 1999\u20132003. J Clin Virol 31(3):165\u2013178","journal-title":"J Clin Virol"},{"issue":"1","key":"451_CR62","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tmaid.2014.10.022","volume":"13","author":"M Jost","year":"2015","unstructured":"Jost M et al (2015) Measles associated with international travel in the region of the Americas, Australia and Europe, 2001\u20132013: a systematic review. Travel Med Infect Dis 13(1):10\u201318","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"451_CR63","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jcv.2013.05.018","volume":"58","author":"B Bankamp","year":"2013","unstructured":"Bankamp B et al (2013) Improving molecular tools for global surveillance of measles virus. J Clin Virol 58(1):176\u2013182","journal-title":"J Clin Virol"},{"issue":"26","key":"451_CR64","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/j.vaccine.2014.03.053","volume":"32","author":"H Buczkowski","year":"2014","unstructured":"Buczkowski H et al (2014) Morbillivirus vaccines: recent successes and future hopes. Vaccine 32(26):3155\u20133161","journal-title":"Vaccine"}],"container-title":["Medical Microbiology and Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0451-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00430-016-0451-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00430-016-0451-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T04:54:06Z","timestamp":1567659246000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00430-016-0451-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s00430-016-0451-4","relation":{},"ISSN":["0300-8584","1432-1831"],"issn-type":[{"value":"0300-8584","type":"print"},{"value":"1432-1831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}